샘플 요청 목록

 카트 문의
시장보고서
상품코드
1513862

세계의 HIV/에이즈 검사 시장

HIV/AIDS Testing
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 202 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

HIV/에이즈 검사 세계 시장은 2030년까지 58억 달러에 달할 전망

2023년에 38억 달러로 추정되는 HIV/에이즈 검사 세계 시장은 2023-2030년간 CAGR 6.1%로 성장하고, 2030년에는 58억 달러에 이를 것으로 예측됩니다. HIV/에이즈 검사 계기는 본 보고서에서 분석한 부문 중 하나이며 CAGR은 5.5%로 성장을 지속하고, 분석 기간 종료 시에는 36억 달러에 달할 것으로 예측되고 있습니다. HIV/에이즈 검사 키트 및 시약 부문의 성장률은 분석 기간 동안 CAGR 7.1%로 추정됩니다.

미국 시장은 추정 10억 달러, 중국은 CAGR 9.9%로 성장 예측

미국의 HIV/에이즈 검사 시장은 2023년에 10억 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 13억 달러 규모에 이를 것으로 예측되며 분석 기간 2023-2030년의 CAGR은 9.9%입니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 2.2%와 6.4%로 예측되고 있습니다. 유럽에서는 독일이 CAGR 3.4%로 성장할 것으로 예측됩니다.

HIV/에이즈 검사: 주요 동향과 촉진요인

HIV/에이즈 검사의 상황은 세계의 건강에의 대처, 기술의 향상, 조기 발견의 중요성에 대한 의식의 높아짐에 의해 크게 전진하고 있습니다. 세계보건기구(WHO)와 유엔합동에이즈계획(UNAIDS) 등 국제기구의 이니셔티브는 HIV/에이즈의 만연을 끝내는 것을 목적으로 하고 있으며, HIV검사서비스 확대를 크게 뒷받침하고 있습니다. 많은 국가에서는 고위험 집단 및 일반 시민에 대해 정기적인 HIV 검사를 의무화하거나 장려하는 국가 정책을 시행하고 있으며, 종종 무료 또는 보조금이 포함된 검사를 제공하는 정부 지원 에 의한 스크리닝 프로그램에 의해 지원됩니다. 이러한 노력은 일반 시민을 대상으로 한 교육 캠페인과 함께 HIV 검사의 보급률과 빈도를 높이고 HIV라는 질병을 비인격화하고 더 많은 사람들이 검사를 받도록 촉구하고 있습니다.

HIV 검사에서 기술의 진보는 이러한 진단 방법의 사용 편의성, 정확성 및 편리성을 빠르게 향상시키고 있습니다. 포인트 오브 케어 검사, 자기 검사 키트, 차세대 시퀀싱(NGS) 및 CRISPR 기반 진단과 같은 혁신적인 진단 플랫폼과 같은 최신 기술은 HIV 진단에 변화를 가져오고 있습니다. 이러한 기술은 노출 후 조기 발견을 가능하게 할 뿐만 아니라 전통적인 건강 관리 환경을 넘어 검사를 확대하고 보다 광범위한 사람들에게 검사를 제공합니다. 또한, 인공지능의 통합은 진단 과정을 간소화하고, 조기 발견을 강화하고, 치료 전략을 개별화하고, 환자 결과를 개선하는 데 매우 중요합니다.

자체 검사 키트와 이동 의료 장치의 상승은 HIV 검사에 대한 접근성을 높이는 데 특히 주목할 만합니다. 자체 검사 키트는 HIV와 관련된 스티그마가 큰 지역에서는 매력적이고 개인적이고 편리한 옵션을 제공하며, 그렇지 않으면 기존 환경을 피할 수 있는 사람들의 검사율을 높입니다. 이동 진료 유닛은 원격지나 충분한 진료를 받지 않은 지역에서도 HIV 검사의 범위를 넓혀 필요한 필수 진단 서비스에 대한 액세스를 더욱 확대합니다. 또한, 검사 전 및 검사 후 상담, 결과 추적 및 관리를위한 원격 의료 및 디지털 플랫폼의 통합은 검사 프로세스의 효율성과 기밀성을 향상시킵니다. 이러한 기술 혁신과 서비스 제공의 혁신은 HIV/AIDS의 관리와 예방에 관한 공중위생의 상황을 개선하고 HIV/AIDS 만연에 대한 세계의 싸움을 추진하고 있다고 생각됩니다.

조사 대상 기업 예(총 12건)

  • Abbott Molecular, Inc.
  • Abbott Molecular, Inc.
  • Bio-Rad Laboratories, Inc.
  • Chembio Diagnostic Systems, Inc.
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • OraSure Technologies, Inc.
  • Siemens Healthineers

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

JHS 24.07.24

Global HIV/AIDS Testing Market to Reach US$5.8 Billion by 2030

The global market for HIV/AIDS Testing estimated at US$3.8 Billion in the year 2023, is expected to reach US$5.8 Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2023-2030. HIV/AIDS Testing Instruments, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$3.6 Billion by the end of the analysis period. Growth in the HIV/AIDS Testing Kits & Reagents segment is estimated at 7.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.0 Billion While China is Forecast to Grow at 9.9% CAGR

The HIV/AIDS Testing market in the U.S. is estimated at US$1.0 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2030 trailing a CAGR of 9.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.2% and 6.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

HIV/AIDS Testing  - Key Trends and Drivers

The landscape of HIV/AIDS testing has seen significant advancements driven by global health initiatives, technological improvements, and heightened awareness of the importance of early detection. Initiatives from international organizations such as the World Health Organization (WHO) and the Joint United Nations Programme on HIV/AIDS (UNAIDS) aim to end the HIV/AIDS epidemic and have significantly driven the expansion of HIV testing services. Many countries have implemented national policies that mandate or encourage regular HIV testing in high-risk populations and the general public, supported by government-backed screening programs that often offer free or subsidized testing. These efforts, along with public education campaigns, have increased testing coverage and frequency, helping to destigmatize the disease and encourage more people to seek testing.

Technological advancements in HIV testing are rapidly enhancing the accessibility, accuracy, and convenience of these diagnostic methods. Modern technologies such as point-of-care tests, self-testing kits, and innovative diagnostic platforms like Next-Generation Sequencing (NGS) and CRISPR-based diagnostics are transforming HIV diagnostics. These technologies not only allow for earlier detection following exposure but also expand testing beyond traditional healthcare settings, reaching broader populations. Furthermore, the integration of artificial intelligence is streamlining the diagnostic process, enhancing early detection, and personalizing treatment strategies, which are crucial for improving patient outcomes.

The rise of self-testing kits and mobile health units is particularly notable in increasing accessibility to HIV testing. Self-testing kits offer a private, convenient option that is appealing in regions where there is significant stigma associated with HIV, increasing testing rates among populations that might otherwise avoid traditional settings. Mobile health units extend the reach of HIV testing into remote or underserved areas, further expanding access to essential diagnostic services. Additionally, the integration of telehealth and digital platforms for pre-test and post-test counseling, result tracking, and management enhances the efficiency and confidentiality of the testing process. These technological and service delivery innovations are set to continue driving the global fight against the HIV/AIDS epidemic, improving the landscape of public health with regards to HIV/AIDS management and prevention.

Select Competitors (Total 12 Featured) -

  • Abbott Molecular, Inc.
  • Abbott Molecular, Inc.
  • Bio-Rad Laboratories, Inc.
  • Chembio Diagnostic Systems, Inc.
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • OraSure Technologies, Inc.
  • Siemens Healthineers

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • HIV/AIDS Testing - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of HIV Infections Globally Strengthens Business Case for Comprehensive Testing Solutions
    • Advances in Diagnostic Technologies Propel Growth of HIV/AIDS Testing Market
    • Increasing Adoption of Home Testing Kits Expands Addressable Market Opportunity for HIV/AIDS Testing
    • Growth in Awareness and Preventive Healthcare Measures Generates Demand for Regular HIV Testing
    • Innovations in Rapid and Point-of-Care Testing Devices Spurs Market Growth for HIV/AIDS Testing
    • Stringent Regulatory Requirements for Diagnostic Accuracy Drives Adoption of High-Precision HIV Tests
    • Focus on Early Detection and Intervention Throws the Spotlight on Advanced HIV Testing Solutions
    • Integration of AI and Machine Learning in Diagnostics Enhances HIV Test Accuracy
    • Rising Investment in Healthcare Infrastructure Generates Opportunities for Innovation in HIV/AIDS Testing
    • Technological Developments in Portable and Wearable Testing Devices Propel Market Expansion for HIV/AIDS Testing
    • Emphasis on Reducing Stigma and Increasing Access Drives Adoption of User-Friendly HIV Testing Solutions
    • Adoption of HIV Testing in Routine Health Check-Ups Expands Addressable Market Opportunity
    • Increasing Use of HIV Testing in High-Risk Populations Accelerates Demand for Comprehensive Screening Solutions
    • Government Initiatives and Funding for HIV/AIDS Research and Prevention Strengthens Business Case for Testing
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for HIV/AIDS Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for HIV/AIDS Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for HIV/AIDS Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Diagnostics Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Diagnostics Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Diagnostics Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World HIV/AIDS Testing Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • HIV/AIDS Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • HIV/AIDS Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • HIV/AIDS Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • HIV/AIDS Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for HIV/AIDS Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for HIV/AIDS Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for HIV/AIDS Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • HIV/AIDS Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • HIV/AIDS Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • HIV/AIDS Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • HIV/AIDS Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for HIV/AIDS Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for HIV/AIDS Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for HIV/AIDS Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • HIV/AIDS Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • INDIA
    • HIV/AIDS Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • HIV/AIDS Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for HIV/AIDS Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for HIV/AIDS Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for HIV/AIDS Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • HIV/AIDS Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for HIV/AIDS Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for HIV/AIDS Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for HIV/AIDS Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • AFRICA
    • HIV/AIDS Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제